The WACC of Biomarin Pharmaceutical Inc (BMRN) is 6.9%.
| Range | Selected | |
| Cost of equity | 6.20% - 8.10% | 7.15% |
| Tax rate | 10.60% - 36.60% | 23.60% |
| Cost of debt | 4.00% - 4.50% | 4.25% |
| WACC | 6.0% - 7.8% | 6.9% |
| Category | Low | High |
| Long-term bond rate | 3.9% | 4.4% |
| Equity market risk premium | 4.6% | 5.6% |
| Adjusted beta | 0.5 | 0.58 |
| Additional risk adjustments | 0.0% | 0.5% |
| Cost of equity | 6.20% | 8.10% |
| Tax rate | 10.60% | 36.60% |
| Debt/Equity ratio | 0.07 | 0.07 |
| Cost of debt | 4.00% | 4.50% |
| After-tax WACC | 6.0% | 7.8% |
| Selected WACC | 6.9% | |